Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/05/2002US6475492 Peptides and assays for the diagnosis of lyme disease
11/05/2002US6475489 Synthesis of human virus antigens by yeast
11/05/2002US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002US6475485 Two novel human cathepsin proteins
11/05/2002US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002EP0792098A4 Enhancing growth and pearl production in mollusks
11/05/2002CA2418798A1 Method of modifying peptide synthetases such that they can n-methylate their substrate amino acids
11/05/2002CA2235128C Transistor-based apparatus and method for molecular detection and field enhancement
11/05/2002CA2147124C Erythropoietin analogs
11/05/2002CA2136831C Uses of nucleic acid analogues in the inhibition of nucleic acid amplification
11/05/2002CA2091449C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/05/2002CA2069437C Process for control of fruit ripening in plants
11/05/2002CA2066777C Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection
11/05/2002CA2011833C Novel polypeptide and production thereof
11/04/2002WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
11/04/2002EP1218486A4 Improvement of clavulanic acid production
11/04/2002EP1163324A4 Genetically modified plants having modulated brassinosteroid signaling
11/03/2002CA2384605A1 Granule-bound starch synthase
11/01/2002CA2380804A1 Method for producing cytosine nucleosides compounds
10/2002
10/31/2002WO2002086454A1 Multi-format sample processing devices, methods and systems
10/31/2002WO2002086450A2 Compositions and methods for the identification of protein interactions in vertebrate cells
10/31/2002WO2002086448A2 Detection of microsatellite instability and its use in diagnosis of tumors
10/31/2002WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002WO2002086441A2 Amplification and detection of mycoplasma pneumoniae
10/31/2002WO2002086167A1 Methods for nucleic acid manipulation
10/31/2002WO2002086165A1 Biological sample processing methods and compositions that include surfactants
10/31/2002WO2002086163A1 Methods for high throughput genome analysis using restriction site tagged microarrays
10/31/2002WO2002086162A1 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device
10/31/2002WO2002086161A1 Method of estimating diplotype from genotype of individual
10/31/2002WO2002086158A2 Method to analyse the kit genotype of pigs
10/31/2002WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002WO2002086147A2 Single nucleotide polymorphisms diagnostic for schizophrenia
10/31/2002WO2002086146A2 Synthetic nucleic acid molecule for imparting multiple traits
10/31/2002WO2002086145A2 Biological sample processing methods and compositions that include surfactants
10/31/2002WO2002086144A2 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002WO2002086140A2 Double-strand nucleic acids with one or two individual strand 5' overhangs, method for production and use thereof
10/31/2002WO2002086134A2 Buffer solution for electroporation and a method comprising the use of the same
10/31/2002WO2002086132A2 Viral vector system to transduce or infect a target adipose tissue site
10/31/2002WO2002086131A1 Gene expression controlling unit and utilization thereof
10/31/2002WO2002086130A2 Production of genetically modified plants with puroindolines
10/31/2002WO2002086129A1 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current
10/31/2002WO2002086128A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/31/2002WO2002086127A1 Acylase gene
10/31/2002WO2002086126A2 Enzymatic method for the enantioselective reduction of keto compounds
10/31/2002WO2002086125A2 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
10/31/2002WO2002086124A2 Human chemokine-13
10/31/2002WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002WO2002086122A2 Protein-protein interactions in adipocytes
10/31/2002WO2002086121A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002WO2002086119A1 Transformed silkworm producing human collagen
10/31/2002WO2002086114A1 Lipoxygenase
10/31/2002WO2002086113A2 Enzyme and snp marker for disease
10/31/2002WO2002086112A2 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002WO2002086111A2 Recombinant alpha-amino ester hydrolases and uses thereof
10/31/2002WO2002086110A2 Flavone synthase i enzymes and the use thereof
10/31/2002WO2002086107A2 A method for differentiating stem cells into insulin-producing cells
10/31/2002WO2002086105A1 Delivery of polynucleotide agents to the central nervous sysstem
10/31/2002WO2002086103A1 A method of nuclear transfer
10/31/2002WO2002086102A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002WO2002086101A2 Core-glycosylated hcv envelope proteins
10/31/2002WO2002086100A2 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002WO2002086098A2 A lac operator-repressor system
10/31/2002WO2002086097A2 Methods for identifying the target of a compound which inhibits cellular proliferation
10/31/2002WO2002086095A2 Transcription factor network discovery methods
10/31/2002WO2002086094A2 Genes involved in isoprenoid compound production
10/31/2002WO2002086091A2 Method to treat hemophilia by hepatic gene transfer of factor viii/ix with vesicle vector
10/31/2002WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002WO2002086087A2 Cytokine protein family
10/31/2002WO2002086085A2 Human timp-1 antibodies
10/31/2002WO2002086079A2 T1r3 a novel taste receptor
10/31/2002WO2002086077A2 Co-expression of zein proteins
10/31/2002WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002WO2002086073A2 Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
10/31/2002WO2002086072A2 Antimicrobial polypeptides and their uses
10/31/2002WO2002086069A2 Secreted proteins
10/31/2002WO2002086068A2 Methods for producing recombinant coronavirus
10/31/2002WO2002086067A2 Mycobacterial sulfation pathway proteins and methods of use thereof
10/31/2002WO2002086066A2 Novel expansin polynucleotides, related polypeptides and methods of use
10/31/2002WO2002086064A2 Inducible expression of transfected genes
10/31/2002WO2002086059A2 Recombinant vaccinia viral vectors
10/31/2002WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
10/31/2002WO2002086057A2 Process for genetic transformation and co-transformation of yeasts
10/31/2002WO2002086051A2 Nucleic acid analysis by mass differentiable oligomers
10/31/2002WO2002086050A2 Ion channel polynucleotide arrays comprising non-conserved regions identifying ion channel family member expression profiles
10/31/2002WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002WO2002085941A2 Modified interferon alpha with reduced immunogenicity
10/31/2002WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002WO2002085939A1 Novel molecules of the card-related protein family and uses thereof
10/31/2002WO2002085938A1 Anti-obesity polypeptides
10/31/2002WO2002085936A1 Mutants of green fluorescent protein
10/31/2002WO2002085935A1 Cell surface layer-binding protein and utilization thereof
10/31/2002WO2002085933A1 Toll-like receptor 5 ligands and methods of use
10/31/2002WO2002085932A2 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002WO2002085434A1 Injection device for administering rna
10/31/2002WO2002085416A1 Viral vectors having reduced virulence
10/31/2002WO2002085340A2 Oligonucleotide compositions and their use to induce differentiation of cells
1 ... 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 ... 4023